Science & Research

Critical Path Initiative

Four images: Woman looking through microscope, Gloved hands holding test tube, Pills coming down a manufacturing shoot., Doctor holding a baby

Transforming the way FDA-regulated products are developed, evaluated, and manufactured


Highlights


About Critical Path

The Critical Path Initiative (CPI) is FDA's national strategy for transforming the way FDA-regulated medical products are developed, evaluated, and manufactured.  ... More

  

Contact FDA

Office of Regulatory Science and Innovation

Carol D. Linden, PhD

Director

301-796-8527

Page Last Updated: 03/17/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.